Dejan Micic to Interleukin-17
This is a "connection" page, showing publications Dejan Micic has written about Interleukin-17.
Connection Strength
0.165
-
Systematic review with meta-analysis: risk of new onset IBD with the use of anti-interleukin-17 agents. Aliment Pharmacol Ther. 2019 08; 50(4):373-385.
Score: 0.165